Myriad Genetics (MYGN) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to -$145.4 million.
- Myriad Genetics' Enterprise Value fell 4554.55% to -$145.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.4 million, marking a year-over-year decrease of 4554.55%. This contributed to the annual value of -$102.4 million for FY2024, which is 2732.43% up from last year.
- Per Myriad Genetics' latest filing, its Enterprise Value stood at -$145.4 million for Q3 2025, which was down 4554.55% from -$74.4 million recorded in Q2 2025.
- In the past 5 years, Myriad Genetics' Enterprise Value registered a high of -$74.4 million during Q2 2025, and its lowest value of -$366.2 million during Q3 2021.
- For the 5-year period, Myriad Genetics' Enterprise Value averaged around -$156.1 million, with its median value being -$121.6 million (2023).
- Per our database at Business Quant, Myriad Genetics' Enterprise Value tumbled by 12830.42% in 2021 and then surged by 7056.84% in 2023.
- Over the past 5 years, Myriad Genetics' Enterprise Value (Quarter) stood at -$338.8 million in 2021, then skyrocketed by 66.09% to -$114.9 million in 2022, then fell by 22.63% to -$140.9 million in 2023, then grew by 27.32% to -$102.4 million in 2024, then plummeted by 41.99% to -$145.4 million in 2025.
- Its Enterprise Value was -$145.4 million in Q3 2025, compared to -$74.4 million in Q2 2025 and -$91.8 million in Q1 2025.